Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10

Kienle, Dirk L.; Dietrich, Daniel; Ribi, Karin; Wicki, Andreas; Quagliata, Luca; Winterhalder, Ralph C.; Koeberle, Dieter; Horber, Daniel; Bastian, Sara; Kueng, Marc; Saletti, Piercarlo; Helbling, Daniel; Baertschi, Daniela; Lugli, Alessandro; Bernhard, Jürg; Andrieu, Christiane; von Moos, Roger (2019). Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. Journal of geriatric oncology, 10(2), pp. 304-310. Elsevier 10.1016/j.jgo.2018.11.011

[img] Text
Kienle SAKK 41-10.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (358kB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Lugli, Alessandro and Bernhard, Jürg

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1879-4068

Publisher:

Elsevier

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

14 Feb 2019 08:56

Last Modified:

23 Oct 2019 05:39

Publisher DOI:

10.1016/j.jgo.2018.11.011

PubMed ID:

30559073

BORIS DOI:

10.7892/boris.124918

URI:

https://boris.unibe.ch/id/eprint/124918

Actions (login required)

Edit item Edit item
Provide Feedback